Drug intelligence / Profile preview

quinapril

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Quinapril is an angiotensin-converting enzyme (ACE) inhibitor prodrug used primarily to treat hypertension and heart failure. It is also indicated for slowing the progression of renal disease. Quinapril works by inhibiting ACE, which catalyzes the conversion of angiotensin I to angiotensin II—a potent vasoconstrictor—thereby reducing blood pressure and decreasing aldosterone secretion. This leads to vasodilation, reduced sodium and fluid retention, and improved cardiac efficiency. Quinapril was developed as a first-line therapy for high blood pressure and can be used alone or in combination with other antihypertensive agents such as thiazide diuretics or beta blockers[1][3][4][5][7].

Brand names
AccuprilAccuretic
Other names
quinapril hydrochloride
02

Targets

ACE (Angiotensin Converting Enzyme)

Beyond the preview

Go deeper on quinapril.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on quinapril.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call